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The expression of gluconeogenic enzymes is typi-
cally repressed when glucose is available. The pro-
tozoan parasite Toxoplasma gondii utilizes host
glucose to sustain high rates of intracellular repli-
cation. However, despite their preferential utilization
of glucose, intracellular parasites constitutively ex-
press two isoforms of the gluconeogenic enzyme
fructose 1,6-bisphosphatase (TgFBP1 and TgFBP2).
The rationale for constitutive expression of FBPases
in T. gondii remains unclear. We find that conditional
knockdown of TgFBP2 results in complete loss of
intracellular growth in vitro under glucose-replete
conditions and loss of acute virulence in mice.
TgFBP2 deficiency was rescued by expression of
catalytically active FBPase and was associated
with altered glycolytic and mitochondrial TCA cycle
fluxes, as well as dysregulation of glycolipid, amylo-
pectin, and fatty acid biosynthesis. Futile cycling
between gluconeogenic and glycolytic enzymes
may constitute a regulatory mechanism that allows
T. gondii to rapidly adapt to changes in nutrient avail-
ability in different host cells.
INTRODUCTION
The protozoan parasite Toxoplasma gondii is a member of the
phylum Apicomplexa, which comprises medically important
pathogens such as Plasmodium and Cryptosporidium species.
T. gondii is estimated to infect nearly one-third of the world’s
human population and is associated with a number of oppor-
tunistic infections, including potentially fatal toxoplasmosis in
immunocompromised individuals and neonates (Weiss and
Dubey, 2009). Acute infections are caused by rapidly dividing ta-
chyzoites, which can infect virtually all nucleated cells of warm-
blooded animals. Following the development of a protective
immune response in immunocompetent individuals, tachyzoites210 Cell Host & Microbe 18, 210–220, August 12, 2015 ª2015 Elsevidifferentiate into non-dividing, encysted bradyzoites that can
persist for the life of the host (Dubey et al., 1998).
T. gondii tachyzoites reside within a unique, non-fusogenic
parasitophorous vacuole within the host cell (Joiner et al.,
1990) and have access to a variety of carbon sources that can
permeate across the limiting membrane of the vacuole (Gold
et al., 2015; Schwab et al., 1994). However, 13C-labeling and ge-
netic studies (Lin et al., 2011; MacRae et al., 2012; Ohsaka et al.,
1982; Starnes et al., 2009) suggest that under normal growth
conditions, intracellular tachyzoites primarily utilize glucose to
generate energy and essential anabolic precursors via glycol-
ysis, the pentose phosphate pathway, and mitochondrial respi-
ration. Tachyzoites also catabolize glutamine in the TCA cycle
under these conditions (MacRae et al., 2012) and can switch to
using this amino acid as a primary carbon source when host
glucose is limiting (Blume et al., 2009).
Despite preferentially utilizing glucose under standard growth
conditions, T. gondii tachyzoites appear to constitutively ex-
press a number of enzymes involved in gluconeogenesis (de
novo glucose synthesis), including two isoforms of the enzyme
fructose 1,6-bisphosphatase (FBPase), which catalyzes the con-
version of fructose 1,6-bisphosphate (FBP) to fructose 6-phos-
phate (Fru6P) (Xia et al., 2008) (http://toxodb.org). T. gondii
FBP1 and FBP2 (TgFBP1, TgFBP2) share structural features
with bacterial FBPs and appear to be of prokaryotic origin (Hines
et al., 2006; Teich et al., 2007). The co-expression of key
regulatory enzymes in glycolysis and gluconeogenesis contrasts
with the situation in many other prokaryotic and eukaryotic mi-
crobes, where expression of gluconeogenic enzymes is typically
repressed when glucose is available, to prevent futile cycling of
ATP and reducing equivalents (Brown et al., 2014; Kronstad
et al., 2012; Xayarath and Freitag, 2012). While the rationale for
constitutive expression of FBPases in T. gondii remains unclear,
it may account for the very modest growth and virulence pheno-
type of parasite mutants lacking the major glucose transporter
(Blume et al., 2009) and the capacity of these parasites to repli-
cate within a wide range of host cell types.
In thisstudyweshowthat theconstitutiveexpressionofTgFBP2
is required for parasite replication in host cells and virulence in
mice. TgFBP2, but not TgFBP1, was shown to be active in vivo
and to support parasite growth under both glucose-limiting ander Inc.
Figure 1. Toxoplasma gondii Constitutively
Expresses TgFBP1 and TgFBP2 in Its
Cytosol
(A) Expression of TgFBP1-HA and TgFBP2-HA in
T. gondii tachyzoites isolated from HFF cultivated
in glucose-replete medium. Western blot of para-
site lysates were probed with a-HA (upper panel)
and a-TgSag1 antibodies (lower panel loading
control).
(B) Indirect immunofluorescence of T. gondii ta-
chyzoites expressing TgFBP1-HA and TgFBP2-HA
under control of endogenous promoters. Tagged
proteins were detected using a-HA antibody 24 hr
post-infection (bar = 5 mm).
(C) TgFBP1 and TgFBP2 mRNA levels in the
T. gondii mutant lacking the major glucose trans-
porter. mRNA levels weremeasured using RT-PCR
and expressed relative to the housekeeping tran-
script for actin. Data represent the mean of three
independent assays performed in triplicate with
SEM (p < 0.05, t test).
(D) The enzyme activity of recombinant TgFBP1
and TgFBP2 in the presence of different FBP
concentrations was measured using an NADP-
linked assay. Data represent the mean of
three independent assays performed in duplicate
with SEM.glucose-replete conditions. Detailed 13C-resolved metabolomic
analyses suggest that TgFBP2 has acquired an important role in
regulating glycolytic fluxes and partitioning of carbon flow into
different pathways of carbohydrate metabolism. The essentiality
of TgFBP2 over widely different conditions of glucose availability
suggests that this enzyme is a potential drug target.
RESULTS
The Two T. gondii FBPase Isoforms Are Active In Vitro,
but Exhibit Different Roles In Vivo
Proteomic analyses of T. gondii tachyzoites have suggested that
these stagesmay constitutively express two isoforms of FBPase,
TgFBP1 and TgFBP2 (GenBank: EPR61430, EPR63671.1,
respectively) under normal (glucose-replete) growth conditions
(Fleige et al., 2008; Xia et al., 2008). To confirm the expression
profile of these proteins, epitope-tagged versions of TgFBP1
and TgFBP2 containing a C-terminal hemagglutinin (HA) epitope
were introduced by single homologous recombination (Fig-
ure S1A). Proteins with the expected molecular size of 43 kDa
were constitutively expressed under normal growth conditions
(Figure 1A) and found to be associated with small puncta uni-
formly distributed throughout the parasite cytoplasm (Figure 1B).
Expression of TgFBP2, but not TgFBP1, was further increased
(approximately 4-fold) in tachyzoites of the glucose transporter-
deficient parasite line Dtggt1 (Blume et al., 2009) (Figure 1C).
These results confirm that TgFBP1 and TgFBP2 are expressed
under glucose-replete conditions and that expression of TgFBP2
may be further upregulated under glucose-limiting growth
conditions.
Both TgFBP1 and TgFPB2 were shown to be active enzymes
when expressed in E. coli with a C-terminal poly-histidine tag orCell Hosan N-terminal GST tag, respectively (Figure S1B). However, sig-
nificant differences were observed in the Vmax, Km for FBP and
sensitivity to AMP (Figure 1D). Specifically, TgFBP2 exhibited
a higher maximum velocity, lower substrate affinity (Table S1),
and a markedly lower susceptibility to AMP inhibition (Fig-
ure S1C). Major differences were also observed in the extent to
which TgFBP1 and TgFBP2were able to complement the growth
phenotypes of S. cerevisiae and E. coli FBPase null mutants.
Specifically, expression of His6-TgFBP2 but not His6-TgFBP1
in the YLR377c yeast FBPase null mutant strain (Gancedo and
Delgado, 1984) restored the capacity of this strain to grow on
non-hexose carbon sources (Figure S1D). Similarly, expression
of GST-TgFBP2 and the unrelated Leishmania major FBPase
(GST-LmjFBP) (Naderer et al., 2006) in the E. coli DF657 FBPase
null mutant restored the ability of this strain to utilize glycerol as
the sole carbon source, while expression of GST-TgFBP1 failed
to support growth (Figures S1E and S1F). Expression of a
mutated version of TgFBP2 (TgFBP2mut) in which two conserved
aspartic acids residues (D148A, D151A) in the putative catalytic
site were replaced with alanine (el-Maghrabi et al., 1993) (Fig-
ure S1G) also failed to restore growth of the E. coli DF657 strain
(Figure S1E). Collectively, these data show that TgFBP2 is an
active FBPase both in vitro and in vivo and is able to restore
gluconeogenesis in heterologous systems, while TgFBP1 only
has demonstrable FBPase activity in vitro.
TgFBP2, but Not TgFBP1, Is Essential for Intracellular
Growth of T. gondii Tachyzoites under Normal Growth
Conditions
To investigate the function of TgFBP1 and TgFBP2 in T. gondii,
we attempted to generate T. gondii mutants lacking individual
genes by double homologous recombination. Mutants lackingt & Microbe 18, 210–220, August 12, 2015 ª2015 Elsevier Inc. 211
Figure 2. Characterization of the Intracel-
lular Growth Phenotype of Dtgfbp1 and
iDtgfbp2 Parasite Lines
(A) Gene knockout constructs for TgFBP1 and
TgFBP2. TgFBP1 was replaced by homologous
recombination using the knockout plasmid pCAT-
TgFBP1ko containing the chloramphenicol ace-
tyltransferase resistance cassette (CAT R.C.).
T. gondii parasites that conditionally expressed
TgFBP2-3HA were generated by insertion of
the plasmid pTET-DHFR-TgFBP2-3xHA, which
contains a dihydrofolate reductase-thymidylate
synthase (DHFR-TS R.C.) expression cassette
(conferring resistance to pyrimethamine) and an
anhydrotetracycline (ATC) suppressible expres-
sion cassette for TgFBP2-3xHA cDNA flanked by
TgFBP2 UTRs.
(B) TgFBP1 mRNA is expressed in the parental
strain but is not detected in Dtgfbp1mutant line as
determined by RT-PCR analysis. In contrast,
TgFBP2 mRNA was transcribed in both strains.
The levels of expression of TgFBP2-3xHA in
iDtgfbp2 parasites cultivated in the presence or
absence of ATC was monitored by western blot
using anti-HA antibodies. A 47 kDa band was
detected in untreated and 12, 24, and 48 hr ATC-
treated parasites, but not after 72 hr. Detection of
the major surface protein TgSag1 with a-TgSag1
antibody was used as a loading control.
(C) Fibroblasts were infected with 200 parental,
Dtgfbp1, and iDtgfbp2 parasites and incubated in
the presence or absence of ATC for 1 week. All
strains displayed similar growth in HFF plaque
assays in the absence of ATC, while growth of
iDtgfbp2 but not of parental parasites was
completely inhibited by ATC.
(D) HFF were infected with iDtgfbp2 (MOI of one)
and ATCwas added at the time of infection or 48 hr
prior to the replication assay (24 hr and 72 hr
treatment time, respectively). Samples were fixed
24 hr post-infection. Dtgfbp1 parasites replicate
normally, whereas intracellular replication of
iDtgfbp2 parasites is completely inhibited by
ATC. Data represent the means of six biological
replicates from two independent experiments
with SEM.TgFBP1 were readily generated after transfection of the linear-
ized pCAT-TgFBP1ko plasmid (Figure 2A, Figures S2A–S2C)
(shown for one clone). Transgenic clones that had undergone
30 and 50 recombination were isolated, and one clone was
shown by RT-PCR to lack the TgFBP1 transcript while still ex-
pressing TgFBP2 mRNA (Figure 2B). The growth rate of the
Dtgfbp1 mutant was indistinguishable from the parental line
when assessed using the fibroblast plaque assay (Figure 2C, Fig-
ure S2G) or direct measurement of intracellular tachyzoite repli-
cation (Figure 2D).
In contrast, similar attempts to delete tgfbp2 were unsuc-
cessful, suggesting that this gene might be essential (data
not shown). We thus generated a parasite line expressing
TgFBP2-3xHA under an anhydrotetracycline (ATC) repressible
promoter. The parental line was transfected with pTET-DHFR-
TgFBP2-3xHA (Figure 2A), in which the TgFBP2 UTRs flanked212 Cell Host & Microbe 18, 210–220, August 12, 2015 ª2015 Elsevithe DHFR resistance cassette and the ATC-repressible TET-
promoter (Meissner et al., 2002) driving the expression of
a TgFBP2-3xHA fusion protein. Following transfection with
the linearized plasmid, several pyrimethamine-resistant para-
site clones (iDtgfbp2) were isolated and shown by PCR to
have undergone double-homologous recombination (shown
for one clone) (Figures S2D–S2F). TgFBP2-3xHA expression
was downregulated in the presence of ATC with complete
loss of detectable protein after 3 days (Figure 2B). Growth of
the iDtgfbp2 mutant in human foreskin fibroblast (HFF) plaque
assays was normal in the absence of ATC, but was completely
blocked by addition of ATC (Figure 2C, Figure S2G). The
reduction in plaque formation in the presence of ATC was
associated with decreased intracellular replication of the
iDtgfbp2 mutant (Figure 2D). These results demonstrate that
TgFBP2, but not TgFBP1, is essential for the survival ander Inc.
Figure 3. TgFBP2, but Not TgFBP1, Is
Required for Gluconeogenesis under
Glucose-Limiting Conditions
(A) HFF were infected with Dtgfbp1 and iDtgfbp2
parasites (MOI of one) and cultured in glucose-
free media for 24 hr. Parasite numbers per vac-
uole were counted and expressed as cell division
post invasion. Mean of six replicates with SEM
from two independent experiments (*p < 0.05,
paired t test).
(B) Extracellular Dtgfbp1 and iDtgfbp2
tachyzoites (48 hr ATC-treated) were suspended
in glucose-free media containing 13C-glutamine
for 4 hr. Gluconeogenesis was assessed by
measuring 13C-enrichment in Glc6P by GC/
MS. Similar levels of 13C-enrichment in citrate
was observed in all cases. Knockdown of
TgFBP2 but not of TgFBP1 inhibits gluconeo-
genesis. Data represent the mean with SEM
of three labeling reactions (*p < 0.05, t test).
Calculation of percent labeling includes all
isotopomers as detailed in Experimental Pro-
cedures.
(C) Dtgfbp1- and iDtgfbp2-infected HFF
were cultured in glucose-free medium contain-
ing 13C-U-glutamine for 4 hr (parental and
Dtgfbp1) or 12 hr (iDtgfbp2), and incorporation
of label into GPI glycolipids was determined by
GC/MS. The de novo synthesis of sugars for GPI
biosynthesis was similar in parental and Dtgfbp1
lines, but markedly reduced in iDtgfbp2 para-
sites after 2-day ATC treatment. Mean of three
independent experiments with SEM, *p < 0.05,
t test.
(D) FBPase activity was measured in cell-free extracts of Dtgfbp1 and iDtgfbp2 lines (72 hr ATC-treated). Loss of TgFBP1 had no effect, while knockdown
of TgFBP2 effectively ablated detectable FBPase activity. Data represent the mean with SEM of two independent experiments with six biological replicates
(*p < 0.05, t test).growth of T. gondii tachyzoites under normal glucose-replete
conditions.
TgFBP2 Is Also Required for Intracellular Growth under
Glucose-Depleted Condition
To investigate whether TgFBP1 and TgFBP2 are differentially
active under different growth conditions, we compared the repli-
cation rates of Dtgfbp1 or iDtgfbp2 (± ATC) parasite lines under
conditions where glucose levels in the host cell are limiting. As
shown previously (Blume et al., 2009), T. gondii tachyzoites
continue to proliferate in HFF that have been cultivated in
glucose-free medium, possibly reflecting the alternative use of
host glutamine under these conditions (Figure 3A). The Dtgfbp1
line replicated to the same extent as the parental strain in
glucose-starved HFF, indicating that TgFBP1 is not essential
for gluconeogenesis (Figure 3A). In contrast, conditional knock-
down of TgFBP2 prevented tachyzoite replication in glucose-
starved HFF (Figure 3A). To directly measure the contribution
that TgFBP1 and TgFBP2 make to gluconeogenesis, parasites
were isolated from glucose-starved HFF and suspended in
glucose-free medium containing 13C-U-glutamine for 4 hr.
GC/MS isotopomer analysis of extracted metabolites from
the three parasite lines showed that 13C-glutamine was catabo-
lized in the mitochondrial TCA cycle and converted to glucose
6-phosphate (Glc6P) to similar extents in the parental andCell HosDtgfpb1 strains (Figure 3B). However, the TgFBP2-deficient
parasites showed markedly reduced incorporation of 13C into
Glc6P (Figure 3B). The residual 13C-label in Glc6P likely reflects
incomplete knockdown of TgFBP2. Thus TgFBP2 appears to
carry most of the gluconeogenic flux under glucose-starvation
conditions.
To confirm that TgFBP2, but not TgFBP1, is active in intra-
cellular stages, infected HFF were cultivated in glucose-free
medium containing 13C-glutamine, and 13C-enrichment in the
major surface glycosyl-phosphatidylinositol (GPI) glycolipids of
isolated parasites was determined. Label was efficiently incor-
porated into the mannose-containing GPI glycan headgroups
of parental and Dtgfbp1 parasites, but not of ATC-treated
iDtgfbp2 parasites (Figure 3C). No incorporation was observed
when infected HFF were labeled with 13C-glutamine in medium
containing 6 mM glucose, confirming that the 13C-glutamine la-
beling of hexose-phosphates and GPI glycans represented
true gluconeogenesis (Figure S4A) (MacRae et al., 2012).
These results suggest that TgFBP2 is responsible for the
majority of FBPase activity in tachyzoites under both glucose-
replete and glucose-limiting conditions. Consistent with this
conclusion, deletion of TgFBP1 had no effect on total FBPase
activity in cell lysates of Dtgfbp1 parasites, while depletion
of TgFBP2 expression resulted in a marked reduction in total
activity (Figure 3D).t & Microbe 18, 210–220, August 12, 2015 ª2015 Elsevier Inc. 213
Figure 4. The Catalytic Activity of TgFBP2 Is Required for Intracel-
lular Growth of T. gondii under Glucose-Replete Conditions
(A) Indirect immunofluorescence of iDtgfbp2 parasites constitutively over-
expressing TgFBP2-myc, TgFBP2mut-myc, Leishmania major FBP-myc
(LmjFBP), E. coli FBP-myc (EcFBP), and TgFBP1-myc under a constitutive
tubulin promoter. 50TgFBP1-myc is driven by its endogenous promoter. All
FBP proteins exhibited a similar punctate distribution in the cytoplasm (scale
bar = 5 mm).
(B) Plaque assay with iDtgfbp2 parasites constitutively expressing the indi-
cated proteins as (C-terminal myc-fusions) under a tubulin promoter. Parasite
lines overexpressing TgFBP2, LmjFBP, or EcFBP exhibit normal intracellular
growth in the presence or absence of ATC after 1 week. Parasites that
overexpress TgFBP1 either under its native or the tubulin promoter (50TgFBP1)
or that overexpress inactive TgFBP2mut do not generate plaques in presence
of ATC.
(C) FBPase activity in cell lysates of iDtgfbp2 knockdown parasites over-
expressing the indicated FBPase enzymes. Parasites were grown for 72 hr in
presence of ATC and lysates were tested for their FBPase activity. Over-
expression of LmjFBP and EcFBP conferred robust cellular FBPase activity
while overexpression TgFBP1 and TgFBP2mut did not. Data represent means
with SEM from at least two independent experiments with at least three
technical replicates (* p < 0.05, t test).
214 Cell Host & Microbe 18, 210–220, August 12, 2015 ª2015 ElseviEnzymatically Active TgFBP2 Is Required for Tachyzoite
Growth under Glucose-Replete Conditions
To confirm that the FBPase activity of TgFBP2 was essential for
tachyzoite growth under glucose-replete conditions, iDtgfbp2
parasites were genetically complemented with epitope-tagged
forms of TgFBP2 or the enzymatically inactive form, TgFBP2mut
(Figure 4A, Figures S3A and S3B). Overexpression of TgFBP2-
myc restored iDtgfbp2 growth in the presence of ATC, while
expression of TgFBP2mut-myc protein failed to rescue growth
(Figure 4B, Figure S3C). Similarly, overexpression of the
FBPases from the unrelated protist Leishmania major or from
E. coli also complemented intracellular growth of iDtgfbp2
in the presence of ATC. In all cases, restoration of growth
was associated with restoration of FBPase activity in cell ly-
sates (Figure 4C). Significantly, overexpression of TgFBP1 in
iDtgfbp2 parasites under either the endogenous or the tubulin
promoter (high levels of expression) (Figures S3A, S3B, and
S3D) did not result in restoration of FBPase activity or rescue
of growth (Figures 4B and 4C). Thus TgFBP1 does not appear
to have demonstrable activity in vivo. This is consistent with
our finding that TgFBP1 does not complement the metabolic
defect of yeast and E. coli FBPase null mutants. These data
demonstrate that tachyzoites are dependent on FBPase activ-
ity for intracellular growth under glucose-replete conditions and
that TgFBP2 is responsible for most if not all of FBPase activity
in vivo.
Loss of TgFBP2 Is Associated with Global Changes in
Central CarbonMetabolism andGlycosylation Pathways
To investigate the consequences of loss of TgFBP2 on tachy-
zoite metabolism, iDtgfbp2-infected fibroblasts were pulse-
labeled with 13C-glucose in the presence or absence of ATC.
Knockdown of TgFBP2 expression had no detectable effect
on the rate of glucose utilization, but led to increased
13C-enrichment in glycolytic metabolites and increased lactate
production. This was accompanied by a decrease in 13C-incor-
poration in all TCA cycle intermediates (Figures 5A and 5B, Fig-
ure S4B), suggesting a diversion of pyruvate or anaplerotic
malate away from mitochondrial metabolism toward lactate
production.
Glycolytic intermediates such as triose phosphates are
utilized for fatty acid biosynthesis in the apicoplast (FASII)
(Ramakrishnan et al., 2012). TgFBP2 knockdown led to a
significant decrease in incorporation of 13C-label from glucose
into plastid-derived fatty acids, such as myristate (C14:0)
and palmitate (C16:0) (Figure 5C). In contrast, incorporation
of label into long and very long chain unsaturated fatty
acids (C18:1, C20:1, C26:1), reflecting ER-localized elonga-
tion and desaturation reactions, was unaffected (Figure 5C).
These changes did not appear to be a consequence of a
non-selective death phenotype, as other indicators of cell
physiology, such as levels of cellular reducing equivalents,
reactive oxygen species, and apicoplast segregation were
unaffected (Figures S5A–S5D). These data suggest that
TgFBP2 has a role in regulating glycolytic flux, most likely by
recycling FBP back to Fru6P, and that loss of TgFBP2 results
in diversion of glycolytic intermediates into lactate produc-
tion and reduced flux into the TCA cycle and FASII fatty acid
biosynthesis.er Inc.
Figure 5. Knockdown of TgFBP2 Results
in Global Changes in Central Carbon
Metabolism
(A) iDtgfbp2 tachyzoites were isolated from
HFF (36 hr with ATC) and incubated in com-
plete medium containing 13C-U-glucose for 4 hr.
13C-enrichment in intermediates in glycolysis
(3PG, 3-phosphoglycerate; PEP, phosphoenol-
pyruvate), the pentose phosphate pathway (r5P,
ribose 5-phosphate; ru5P, ribulose 5-phosphate),
and the TCA cycle was determined by GC/MS.
13C labeling of glycolytic intermediates was
elevated in ATC-treated cultures (ANOVA, p < 0.05)
and reduced in TCA cycle intermediates (ANOVA,
p < 0.0005) (mean of five independent experiments
with SEM). See also Figure S4B for metabolite
abundances.
(B) iDtgfbp2-infected HFF (MOI = 1.5) were
cultured in the presence or absence of ATC and
medium containing 6 mM 13C-glucose for 28 hr,
and levels of glucose (black bars) and 13C-lactate
(gray bars) in the culture supernatant were
determined by GC/MS. Data were normalized to
parasite numbers. Glucose uptake was similar in
uninfected and infected HFF, while lactate pro-
duction was increased in ATC-treated iDtgfbp2
parasites (t test, p < 0.005). Values represent the
mean of three biological replicates with SEM.
(C) iDtgfbp2-infected HFF were incubated in the
presence or absence of ATC for 36 hr and labeled
with 13C-glucose. De novo synthesis of fatty
acids via the apicoplast-located FASII pathway
(up to C16:0) or the ER elongase pathway
(from C18:0 to C26:1) was assessed by analysis of
13C-enrichment in total cellular fatty acids, as
determined by GC/MS. Synthesis of myristic acid
but not very long chain fatty acids was impaired
following knockdown of TgFBP2. Mean percent
13C-enrichment from five independent experi-
ments with SEM (p < 0.05).
(D) iDtgfbp2 parasites synthesize decreased
amounts of sugar nucleotides. Parasites were
treated with ATC for 48 hr and incubated for 1 hr
with 13C-glucose after egress. The turnover of
UDP-hexose was determined by LC/MS analysis
of total cytosolic extracts (mean of three indepen-
dent experiments with SEM, p < 0.05, t test).
(E) Intracellular iDtgfbp2 parasites were treated
for 36 hr with ATC and parasites were labeled
with 13C-glucose for 12 hr. 13C-enrichment in the
mannose headgroups of parasite GPI glycolipids
was determined after solvolysis and analysis of the released mannose methyl esters by GC/MS. Data represent the mean and SEM from three independent
experiments (p < 0.005, t test).
(F) iDtgfbp2 parasites synthesize less amylopectin from glucose after 36-hr ATC treatment. Infected HFF were labeled with 13C-glucose (4 hr) and the turnover
of amylopectin was determined after hydrolysis of delipidated cell lysates and GC/MS analysis of released glucose (mean of four experiments with SEM,
p < 0.005, t test).
(G) Knockdown of TgFBP2 leads to decreased synthesis of dolichol-P-mannose (DL) and glycosylphosphatidylinositol precursors (GPI). Cell-free lysates of
iDtgfbp2 parasites isolated from HFF (following 48 hr growth in the presence or absence of ATC) were incubated with GDP-3H-man to label intermediates in
dolichol-P-mannose/oligosaccharide and GPI biosynthesis. Labeled lipids were analyzed by HPTLC and detected by fluorography. The HPTLC mobility of DL
and GPI are indicated. Lipid species were identified by mild base and acid treatments (Figure S4C, Figure S5C).Loss of TgFBP2 Results in General Dysregulation of
Hexose Phosphate Metabolism
Sugar phosphates are also catabolized via the pentose phos-
phate pathway or converted to sugar nucleotides for glycocon-
jugate biosynthesis. No change was observed in 13C-glucose
labeling of pentose phosphate pathway intermediates followingCell Hosrepression of TgFBP2 expression in iDtgfbp2-infected HFF
(Figure 5A). On the other hand, the labeling of sugar nucleotide
pools was significantly decreased (Figure 5D). Decreased label-
ing of these pools was associated with reduced turnover of the
GPI glycolipids (Figure 5E) and the major intracellular carbohy-
drate reserve, amylopectin (Figure 5F). Amylopectin synthesist & Microbe 18, 210–220, August 12, 2015 ª2015 Elsevier Inc. 215
Figure 6. TgFBP2 Is Required for Virulence in Mice
(A and B) Six C57BL/6 mice were infected with parental, iDtgfbp2, or geneti-
cally complemented iDtgfbp2-tgfbp2 tachyzoites (105) and provided with ATC
in their drinkingwater (A). The infectionwas assessed bymeasuring changes in
relative body weight and white blood cells (B). ATC was omitted from drinking
water from day 12 onward. Means with SEM are shown from one experiment.
Asterisked time points differ significantly between iDtgfbp2 and both control
groups (t test, p < 0.05).
(C) Parasite numbers in peritoneal cells at day 7 post-infection. Five out of six
mice from the wild-type and iDtgfbp2+tgfbp2-infected group and three of six
from the iDtgfbp2 infected groupwere sacrificed on day 7 for parasite counting
in the peritoneum. The bar indicates the average and the error bar SEM from
one experiment. Counts of individual mice are shown as symbols.is normally increased in slow-growing parasite stages (Gue´rardel
et al., 2005; Lin et al., 2011), suggesting that the decreased flux
into amylopectin synthesis following downregulation of TgFBP2
expression is a direct consequence of reduced flux into glycan
synthesis and not due to slow parasite growth. This was further
confirmed by independently arresting parasite growth with 5-flu-
orodeoxyuridine (FUDR) (Figure S5E). In contrast to the pheno-
type observed following repression of TgFBP2, FUDR treatment
resulted in a 3-fold accumulation of amylopectin pools. FUDR
treatment had a modest effect on GPI and fatty acid synthesis
(Figures S5F–S5H), suggesting that the reduced labeling of these
membrane components following repression of TgFBP2 expres-
sion may reflect, in part, reduced parasite growth.
The activity of ER glycosylation pathways can also be as-
sessed by measuring the steady-state concentrations of doli-
chol-linked oligosaccharide and GPI glycolipid intermediates in
crude microsomal preparations (Naderer et al., 2008). Micro-
somes were prepared from iDtgfbp2 parasites, with or without
prior ATC treatment, and labeled with GDP-3H-Man in order to
tag pre-existing ER acceptors, such as dolichol-phosphate, do-
lichol-PP-GlcNAc2, and GlcN-PI (Naderer et al., 2008). Synthesis
of dolichol phosphomannose and several GPI intermediates was
markedly repressed in microsomes from ATC-treated iDtgfbp2
parasites (Figure 5G, Figure S4C), suggesting a defect in apico-
plast-dependent polyprenol synthesis in addition to, or separate216 Cell Host & Microbe 18, 210–220, August 12, 2015 ª2015 Elsevifrom, downregulation of glycosylation pathways. Collectively,
these data show that loss of TgFBP2 activity is associated with
global defects in several important glycosylation pathways.
Repression of TgFBP2 Results in Attenuated Virulence
in Mice
To investigate whether expression of TgFBP2 is important for
parasite virulence, C57BL/6 mice were infected with a high
dose (105) of parasites of the parental, iDtgfbp2, and comple-
mented iDtgfbp2+tgfbp2 strains, and expression of inducible
copies of TgFBP2 was repressed by providing infected mice
with ATC in their drinking water. Infection with the parental and
iDtgfbp2+tgfbp2 parasite lines was associated with a pro-
nounced decrease in body weight after 6–7 days (p < 0.005), at
which point mice were euthanized (Figure 6A). In contrast,
mice infected with the iDtgfbp2 mutant maintained normal
body weight throughout this period. Mice infected with the
parental or iDtgfbp2+tgfbp2 parasites contained high parasite
numbers (> 104) in the peritoneum at day 7, while no parasites
were detected in half of the mice infected with iDtgfbp2 (Fig-
ure 6C). The other iDtgfbp2-infected mice showed no signs of
infection by day 12, as shown by restoration of normal white
blood cell counts and body weight (Figure 6B). Removal of
ATC from the drinking water on day 12 did not result in recurrent
signs of disease over the following 7 days, indicating the
absence of a persistent population of viable parasites. Thus,
depletion of TgFBP2 leads to complete loss of acute virulence
of the hyper-virulent type I strain in mice.
DISCUSSION
Microbial pathogens typically respond to changes in carbon
source availability in their host niches by transcriptionally upre-
gulating enzymes involved in the catabolism of preferred carbon
source while repressing enzymes involved in the catabolism of
other carbon sources (Brown et al., 2014; Kronstad et al.,
2012; Xayarath and Freitag, 2012). In contrast, T. gondii tachy-
zoites appear to constitutively express many enzymes involved
in central carbon metabolism, suggesting that post-transcrip-
tional mechanisms play a key role in regulating major metabolic
fluxes and carbon source utilization (Fleige et al., 2008; Xia et al.,
2008). In this study we show that the constitutive expression of
the gluconeogenic enzyme, TgFBP2, is required for intracellular
parasite replication under both glucose-replete and glucose-
limiting growth conditions and for acute virulence of the parasite
in mice. Based on detailed metabolomic analyses, we propose
that the co-expression of enzymes involved in glycolysis and
gluconeogenesis contributes to robust regulation of central
carbon metabolism via futile metabolic cycling. This mechanism
may also increase the capacity of these parasites to rapidly
adapt to changing nutrient conditions in their host cells and
thus expand their host cell range.
We have previously shown that tachyzoites scavenge and
co-catabolize both glucose and glutamine from their host cell,
which allows them to sustain high rates of intracellular repli-
cation (Blume et al., 2009; MacRae et al., 2012). While scav-
enged glucose is catabolized via a number of pathways,
including glycolysis, the pentose phosphate pathway, and the
TCA mitochondrial cycle (MacRae et al., 2012), glutamine iser Inc.
Figure 7. T. gondii FBP2 Is Required for
Both Gluconeogenesis and Normal Glucose
Catabolism
(A) TgFBP2 may participate in a futile cycle
with phosphofructokinase (TgPFK) under
glucose-replete conditions regulating intracel-
lular levels of hexose phosphate and phos-
phate/ pyrophosphate (Pi/PPi). Loss of TgFBP2
under these conditions leads to increased
glycolytic flux and changes in the extent to
which glucose carbon skeletons are catabo-
lized in the TCA cycle or used for fatty acid
(FASII) and isoprenoid (DOXP) synthesis in
the apicoplast (red arrows). Synthesis of sugar
nucleotides, amylopectin, and the assembly of
essential N-glycans and GPI glycolipid pre-
cursors is also reduced following loss of TgFBP2
expression.
(B) Under glucose-limiting growth conditions,
TgFBP2 fulfills a classic gluconeogenic function,
together with phosphoenolpyruvate carbox-
ykinase (PEPCK) and pyruvate carboxylase (PC),
in channeling intermediates from the TCA cycle to
hexose-phosphates. Metabolites derived from glucose (red), glutamine (blue), or both carbon sources (dark purple) are indicated. Dashed arrows symbolize
multiple reactions. OAA, oxaloacetate; GABA, g-aminobutyric acid; PEPCK, phosphoenolpyruvate carboxykinase; PC, pyruvate carboxylase.only catabolized in the TCA cycle, with minimal feed of carbon
skeletons into gluconeogenesis (MacRae et al., 2012). The pre-
dominance of glycolytic flux under normal growth conditions is
supported by the finding that aldolase null mutants accumulate
upstream intermediates in glycolysis, such as FBP (Shen and
Sibley, 2014). In this context, the finding that T. gondii tachy-
zoites are dependent on the expression of functionally active
TgFBP2 for intracellular growth in HFF under normal growth
conditions was surprising. Parasite growth could be rescued
by heterologous expression of unrelated FBPases from
L. major and E. coli, but not by expression of enzymatically inac-
tive TgFBP2mut, indicating that expression of an active FBPase is
essential for intracellular growth. Significantly, the loss of func-
tion of TgFBP2 was not compensated for by either endogenous
levels of expression or overexpression of TgFBP1. While
TgFBP1 retains FBPase activity in vitro, it is strongly inhibited
by AMP and appears to be minimally active in vivo in both
T. gondii tachyzoites and following heterologous expression in
yeast and E. coli. Whether TgFBP1 is active in other develop-
mental stages or fulfills other as yet undefined functions remains
to be determined. Collectively, these data suggest that the
FBPase activity of TgFBP2 is required for tachyzoite growth un-
der normal glucose-replete growth conditions.
Knockdown of TgFBP2 was associated with global changes in
flux through glycolysis, the TCA cycle, and anabolic pathways
involved in fatty acid, glycoconjugate, and isoprenoid biosyn-
thesis (Figure 7). While the precise mechanism by which TgFBP2
regulates these carbon fluxes remains to be determined, we
show that TgFBP2 is active under glucose-replete conditions
and may thus participate in a metabolic futile cycle with the
glycolytic enzyme pyrophosphate-dependent phosphofructoki-
nase (TgPFK) (Peng and Mansour, 1992). This cycle could pre-
vent the accumulation of toxic levels of FBP under conditions
of high glycolytic flux (Shen and Sibley, 2014) and/or regulate
overall glycolytic flux. An analogous metabolic cycle, involving
the diversion of Glc6P into trehalose synthesis, has recentlyCell Hosbeen shown to be important for regulating glycolysis in yeast
(van Heerden et al., 2014). Futile cycling between Fru6P and
FBP may also play a critical role in maintaining the steady-
state pools of hexose-phosphates and fluxes into non-glycolytic
pathways, such as the pentose phosphate pathway and glyco-
conjugate biosynthesis. While 13C-glucose labeling of pentose
phosphate pathway intermediates was not appreciably changed
following repression of TgFBP2 expression, we observed a dra-
matic decrease in synthesis of free GPI glycolipids and amylo-
pectin, suggesting that depletion of TgFBP2 leads to decreased
synthesis of sugar nucleotides and glycoconjugate biosynthesis.
Interestingly, the genomes of related apicomplexan parasites
belonging to the genus Plasmodium lack an identifiable FBPase
gene. However, asexual red blood cell stages of P. falciparum
express a novel haloacid dehydrogenase (HAD1) that can de-
phosphorylate sugar phosphates and glycolytic intermediates
and appears to have a role in regulating glycolytic flux and
channeling intermediates into the plastid biosynthesis pathways
(Guggisberg et al., 2014). Thus futile metabolic cycles may
contribute to metabolic regulation in other parasitic protozoa.
Together, these data suggest that co-expression of TgFBP2
and TgPFK constitutes a functionally important futile cycle de-
signed to regulate flux through glycolysis and interconnected
pathways of carbohydrate metabolism.
Loss of TgFBP2 expression strongly attenuated virulence
in mice. While our data suggest that TgFBP2 is essential for
parasite growth in host cells that maintain high intracellular
concentrations of glucose (Behjousiar et al., 2012), TgFBP2
may also facilitate parasite growth in host cells in which
intracellular glucose levels may fluctuate. In particular, glucose
levels in muscle cells and neurons (Dubey, 1997), may fluc-
tuate during periods of intensive metabolic activity and/or
following depletion of short-term carbohydrate stores (Berg-
stro¨m et al., 1967; Saez et al., 2014). Constitutive expression
of TgFBP2 may thus enable rapid fine-tuning of parasite
carbon metabolism over a wide range of nutrient conditions int & Microbe 18, 210–220, August 12, 2015 ª2015 Elsevier Inc. 217
the host cell and possibly contribute to the ability of these
parasites to robustly proliferate within many different host cell
types. Whether TgFBP2 is required for the differentiation of
tachyzoites to encysted bradyzoites or other developmental
stages remains to be determined. Loss of TgFBP2 was associ-
ated with a decrease in amylopectin synthesis that may compro-
mise the viability of the latter stages. Our attempts to generate
conditional TgFBP2 mutants in the readily differentiating type 2
Prugnaud strain by either replacing TgFBP2 UTRs with regula-
tory elements derived from the tachyzoite specific sag1 gene
or tagging TgFBP2 with a destabilization domain (DD) were not
successful.
In summary, we show that T. gondii is dependent on the
expression of a functional FBPase for normal glucose meta-
bolism. TgFBP2 appears to have acquired a regulatory function
under glucose-replete conditions through its capacity to modu-
late early glycolytic flux, while also maintaining its capacity to
sustain gluconeogenesis under glucose-limiting conditions.
The constitutive coexpression of glycolytic and gluconeogenic
enzymes may allow tachyzoites to exploit fluctuating or variable
hexose levels in a wide range of cell types. Our findings raise the
possibility that key enzymes in central carbon metabolism are
potential drug targets.
EXPERIMENTAL PROCEDURES
Parasite Culture, Transfection, Growth Assays, and Differentiation
T. gondii tachyzoites of the type1 RH Dku80::dhfr and RH-TATi Dku80::ble
strains and the type2 strain Pru Dku80::hxgprt (Fox et al., 2011; Huynh and
Carruthers, 2009; Sheiner et al., 2011) were maintained at 37C in confluent
monolayers of human foreskin fibroblasts (HFF) cultured in DMEMmedia sup-
plemented with 10% FCS, 10 units/ml penicillin, and 100 mg/ml streptomycin
at 37C at 10% CO2. Please refer to Supplemental Experimental Procedures
for parasite transfection, differentiation, and growth assays.
Generation of Plasmids
All constructs were made by restriction enzyme-mediated cloning using
primers shown in Supplemental Experimental Procedures.
Immunoblot and Immunofluorescence Assays
For western blot analysis, we used a-TgSag1 (1:1,000) (Burg et al., 1988),
mouse a-IMC1 (mAb 45.36, kindly provided by Gary Ward), rabbit a-HA
(C29F4, NEB), rat a-HA (3F10, Roche), and a-myc (9E10) with HRP-conjugated
secondary antibodies for ECL detection. Immunofluorescence assays were
performed as previously described (Blume et al., 2009) using primary rabbit
a-HA (NEB), a-myc, a-TgGap45 (kind gift from Dominique Soldati), and
a-TgCpn60 (kind gift from Geoff McFadden) antibodies. Secondary Alexa-
488- or Alexa-594-conjugated antibodies were used for detection. All samples
were Hoechst stained and imaged on a Delta Vision Elite microscope and pre-
sented as maximum projections of deconvoluted image stacks SoftWORX).
Transfection of E. coli and S. cerevisiae FBPase Mutants
Refer to Supplemental Experimental Procedures.
Protein Expression on E. coli
TgFBP1-HIS6 and GST-TgFBP2-HIS6 were expressed in BL21DE3 cells from
pET22b(+) and pET41a(+) plasmids, respectively, and purified from cell lysates
using Ni-NTA columns (Supplemental Experimental Procedures).
FBPase Enzyme Assays
Extracellular parasites were filter purified, PBSwashed, and lysed in hypotonic
lysis buffer (1 mM HEPES [pH 7.4], 2 mM EGTA, 2 mM DTT, EDTA-free prote-
ase inhibitor cocktail [Roche]) for 3 min with water bath sonication. Cell equiv-
alents (5 3 105) were added to assay buffer (50 mM HEPES [pH 7.4], 0.2 mM218 Cell Host & Microbe 18, 210–220, August 12, 2015 ª2015 ElseviEGTA, 10 mM MgSO4, 2 mM ATP, 1 mM NADP, protease inhibitors, 2 U/ml
G6DH [Sigma], phosphoglucoisomerase [Roche]). Reactions were initiated
by addition of FBP and absorbance at OD340 was recorded at room tem-
perature every 47 s for 4 hr in a Bio-Tek plate reader. FBPase activity was
calculated as the maximum absorbance increase by linear regression. GST-
TgFBP2-HIS6 or TgFBP1-HIS6 (50 mg/l) was suspended in assay buffer
(50 mM HEPES, 10 mMMgSO4, 0.2 mM EDTA, 0.25 mM NADP, 1 U/ml phos-
phoglucoisomerase, 0.96 U/ml G6DH [Sigma]) containing 2 mM NaHPO4 or
0.2 mM NaHPO4, respectively. Activity was measured as described above.
Data were plotted and Km and vmax parameters were calculated in GraphPad
Prism software (version 5.01) assuming Michaelis-Menten kinetics. Assay
negative controls included empty vector sample, no FBPase, no lysate, and
no substrate and did not lead to detectable absorbance changes.
Metabolic Labeling, Extraction, and Metabolite Analysis via Gas
Chromatography or Liquid Chromatography-Tandem Mass
Spectrometry
Stable isotope labeling experiments were carried out as described previously
(MacRae et al., 2012). Briefly, T. gondii-infected HFF (36 hr post-infection,
MOI=3) or freshlyegressedextracellularparasiteswere suspended in freshme-
diumcontaining either 13C-U-glucoseor 13C-glutamine inplace of non-enriched
glucose/glutamineand incubated for4hror indicated times.Labelingof infected
HFF was terminated by rapid exchange of labeling media with excess ice-cold
PBS and transfer of the flasks onto an ice-water slurry. Free parasite suspen-
sions were quenched in an ethanol-dry ice bath and washed with ice-cold
PBS. Intracellular parasites were released via scraping and syringing through
a 27Gneedle and filter-purified prior to extraction in chloroform:methanol:water
(1:3:1 v/v) (see Supplemental Experimental Procedures for additional details).
GDP-[2-3H]-Mannose Labeling
GDP-[2-3H]-mannose labeling was done as described previously (Naderer
et al., 2008). In brief, syringe-released and filter-purified tachyzoites were
hyptonically permeabilized (1 mM HEPES [pH 7.4], 2 mM EGTA, 2 mM DTT,
EDTA-free protease inhibitor cocktail [Roche]) and the cell-free lysates
were incubated at 30C with 3.5 Ci/mmol GDP-[2-3H]-mannose for 35 min.
3H-labeled lipids were extracted in chloroform and methanol (1:2 v/v) and
recovered after drying and phase partitioning in 1-butanol:water (2:1 v/v).
3H-lipids were analyzed by HPTLC, with or without prior mild acid treatment
(0.5 M HCl, 15 min, 55C) or base hydrolysis (0.1 M methanolic NaOH, 2 hr,
37C) to identify acid- and base-labile species.
T. gondii Mice Infection
C57BL/6mice infection studies were carried out in accordancewith guidelines
of the Walter and Eliza Hall Institute Animal Ethics Committee. Mice were in-
fected by intraperitoneal injection. Drinking water was supplemented with
0.2 mg/ml ATC for the indicated time period. Automated cell counts were per-
formed on blood collected from the retro orbital plexus into microtainer tubes
with EDTA, using an Advia 2120 hematological analyzer (Siemens). Mice were
sacrificed by CO2 inhalation, and parasites were recovered by intraperitoneal
lavage with PBS.
Transcript Expression by Real-Time PCR, Detection of Reactive
Oxygen Species, and NADPH/NADP Ratios and Apicoplast
Segregation Assays
Please refer to Supplemental Experimental Procedures for detailed methods.
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